These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15713523)

  • 41. Concurrent chemoradiation therapy with docetaxel/cisplatin followed by docetaxel consolidation therapy in inoperable stage IIIA/B non-small-cell lung cancer: results of a phase I study.
    Huber RM; Borgmeier A; Flentje M; Willner J; Schmidt M; Manegold C; Bramlage P; Debus J
    Clin Lung Cancer; 2010 Jan; 11(1):45-50. PubMed ID: 20085867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer.
    Yamamoto N; Nishimura Y; Nakagawa K; Matsui K; Fukuoka M
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):285-91. PubMed ID: 16416334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: a phase I/II study with 5 years' follow-up.
    Brunsvig PF; Hatlevoll R; Berg R; Lauvvang G; Owre K; Wang M; Aamdal S
    Lung Cancer; 2005 Oct; 50(1):97-105. PubMed ID: 16005105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.
    Sen F; Saglam EK; Toker A; Dilege S; Kizir A; Oral EN; Saip P; Sakallioglu B; Topuz E; Aydiner A
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1497-505. PubMed ID: 21499895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
    Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS
    Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction combination chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
    Herse B; Dalichau H; Wörmann B; Hemmerlein B; Schmidberger H; Hess CF; Hannemann P; Criée CP; Hiddemann W; Griesinger F
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):298-302. PubMed ID: 9885122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.
    Felip E; Del Campo JM; Bodi R; Vera R; Casado S; Rubio D
    Am J Clin Oncol; 1997 Aug; 20(4):404-6. PubMed ID: 9256899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fractionated scheme of oral vinorelbine as single-agent therapy or in combination with cisplatin concomitantly with thoracic radiotherapy in stage III non-small-cell lung cancer: dose-escalation phase I trial.
    Krzakowski M; Lucas C; Gridelli C
    Clin Lung Cancer; 2014 Jul; 15(4):266-73. PubMed ID: 24954229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinoma.
    Page RD; Smith FP; Geils GF; Beall CL; Fridman M; Allen BJ
    Cancer; 2005 Nov; 104(9):1956-61. PubMed ID: 16177986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
    Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
    Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC).
    Patel SH; Ajlouni M; Chapman R; Lu M; Movsas B; Kim JH
    J Thorac Oncol; 2007 Sep; 2(9):831-7. PubMed ID: 17805061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term survival following concurrent chemoradiotherapy in patients with non-small-cell lung cancer with concomitant brain metastases only.
    Harita S; Mizuta A; Kuyama S; Kikuchi T
    Int J Clin Oncol; 2005 Feb; 10(1):63-8. PubMed ID: 15729604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
    Belani CP; Pereira JR; von Pawel J; Pluzanska A; Gorbounova V; Kaukel E; Mattson KV; Ramlau R; Szczesna A; Fidias P; Millward M; Fossella F;
    Lung Cancer; 2006 Aug; 53(2):231-9. PubMed ID: 16787687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
    Komaki R; Scott C; Lee JS; Urtasun RC; Byhardt RW; Emami B; Andras EJ; Asbell SO; Rotman M; Cox JD
    Am J Clin Oncol; 1997 Oct; 20(5):435-40. PubMed ID: 9345325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weekly vinorelbine and docetaxel as second-line chemotherapy for pretreated non-small cell lung cancer patients: a phase I-II trial.
    Nelli F; Naso G; De Pasquale Ceratti A; Saltarelli R; Dauria G; Lugini A; Ferraldeschi R; Picone V; Moscetti L; Cortesi E
    J Chemother; 2004 Aug; 16(4):392-9. PubMed ID: 15332716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.
    Park J; Ahn YC; Kim H; Lee SH; Park SH; Lee KE; Lim DH; Park J; Kim K; Jung CW; Im YH; Kang WK; Lee MH; Park K
    Lung Cancer; 2003 Nov; 42(2):227-35. PubMed ID: 14568691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer.
    Center B; Petty WJ; Ayala D; Hinson WH; Lovato J; Capellari J; Oaks T; Miller AA; Blackstock AW
    J Thorac Oncol; 2010 Jan; 5(1):69-74. PubMed ID: 20035186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984).
    Biesma B; Manegold C; Smit HJ; Willems L; Legrand C; Passioukov A; van Meerbeeck JP; Giaccone G;
    Eur J Cancer; 2006 Jul; 42(10):1399-406. PubMed ID: 16759850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
    Pérol M; Guérin JC; Thomas P; Poirier R; Carles P; Robinet G; Kleisbauer JP; Paillotin D; Vergnenègre A; Balmes P; Touron D; Grivaux M; Pham E
    Lung Cancer; 1996 Feb; 14(1):119-34. PubMed ID: 8696715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.